Sansure Biotech Inc. products

Respiratory infections are classified into the upper respiratory tract infections and lower respiratory tract infections. It refer to the pathogens that infect the nose, throat, trachea, bronchi or lungs, which principally cause diseases of tissues and organs outside the respiratory tract, manifested by fever, sore throat, cough, headache and other symptoms. The respiratory tract pathogen has the characteristics of strong infectivity, rapid spread, short incubation period and acute onset, etc. which seriously harm human health. After respiratory infection, symptoms are mostly similar. Sansure six respiratory pathogens joint detection kits can help doctors make differential diagnosis, accurately detect the pathogens that cause symptoms, and formulate treatment plans.

The Respiratory Pathogens Multiplex Nucleic Acid Diagnostic Kit (Multiplex PCR-Fluorescence Probing) is intended for the simultaneous qualitative detection of seven types of common clinical pathogens in the lower respiratory tract, including klebsiella pneumoniae, streptococcus pneumoniae, haemophilus influenzae, pseudomonas aeruginosa, legionella pneumophila, Bordetella pertussis and staphylococcus aureus in sputum. The detection results can be used for the auxiliary diagnosis of the patients with lower respiratory tract infection or suspected lower respiratory tract infection and providing the molecular diagnostic basis for the lower respiratory tract pathogen infection. The detection results of this diagnostic kit is only for clinical reference, and can not be used as the only criterion of clinical diagnosis.It’s recommended that the disease should be a comprehensive analysis with the patient’s clinical manifestation and the detection from other laboratory.

Mycobacterium tuberculosis virus (TB) is a pathogenic bacterium that causes tuberculosis. It is likely to infect all human tissues and organs, especially the lungs to cause pulmonary tuberculosis. Early diagnosis and treatment are important for effective control of tuberculosis. In recent years, with the development of molecular biology, nucleic acid fluorescence quantitative PCR method based on the mycobacterium tuberculosis nucleic acid has drawn more and more attention from researchers.

Mycoplasma pneumoniae (MP) is a pathogenic microorganism between bacteria and virus. It is mainly transmitted through buccal and nasal mucus by the air causing respiratory diseases, with the highest incidence in children and adolescents. Respiratory infection has the manifestations of pharyngitis and bronchitis, with a few cases causing infection to the lung. Recently, incidence among infants and children is increasing, therefore, early diagnosis and treatment can decrease the exacerbation of acute pneumonia in children. The development of molecular biology also draws more attention to the fluorescence quantitative PCR technology for the detection of MP-DNA. This diagnostic kit is an in vitro nucleic acid amplification test for the detection of mycoplasma pneumoniae DNA in humansputum and throat swab. It is intended for use as an aid in the diagnosis of an MP infection and providing a molecular-diagnostics-based solution.

Acute infectious diseases caused by adenovirus easily affect the mucous membranes of the respiratory and digestive tracts, the conjunctiva of the eyes, the urinary tract and the lymph nodes. The main manifestation is an acute upper respiratory tract infection. The population is generally susceptible, mostly the children. Infants are susceptible to adenovirus pneumonia, which is severe and has a high mortality rate. The source of infection is the patient and the latent infected person. The virus is excreted from the respiratory tract and conjunctival secretions, feces and urine, and is transmitted by airborne droplets, close contact and the feces-oral route.

This diagnostic kit is an in vitro nucleic acid amplification test for the detection of low-risk papillomavirus (HPV)(type 6/11) DNA in reproductive tract secretions. It is intended for use as an aid in diagnosing an HPV (type 6/11) infection and patients with clinically suspected genital warts.

One Robot Doing Two Robots’ Job: 48 samples throughput≤100 min. (one-tube fast release technology 96 samples at less than 40 min.), minimum 3 batches (48 samples/batch x3) per day per unit, save lab space, high cost-effectiveness.

Precise Temperature Control System: The SLAN®system adopts Peltier technology which can accurately and quickly control increases and decreases of temperature with a precision of ±0.1? and features long service life, no noise and no pollution, etc.; Multiple-point temperature control technology ensures the uniformity between different wells. The temperature correction technology guarantees the accuracy of temperature and thus ensures the accuracy of assay result; PCR tube temperature-control technology guarantees the accuracy of actual temperature of reagent in the tube and enables the SLAN®to easily adjust for different reactions using different volumes.

COVID-19 is an infectious disease caused by a newly discovered coronavirus named SARS-CoV2. Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Elder people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. Sansure COVID-19 diagnostic solutions are used to directly detect  the presence of viral RNA, which will be detectable in patients before antibodies form or symptoms of the disease are present, which means the test results can tell whether or not that someone gets virus very early on in their illness.

This High-risk HPV DNA (Genotype) Diagnostic Kit (PCR-Fluorescence Probing) is an in vitro nucleic acid amplification test for the detection of high-risk HPV (type 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68) present in exfoliated cells from females’ cervix. The test results can be used for identification of HPV genotypes.